HSPD1 and cancer: KIRA6 is a prototype of ATP-binding compounds disrupting the oligomerization and RNase activities of IRE1α and suppresses the HSP60–IKKβ-mediated activation of Nf-kB-mediated pro-inflammatory response in cancers (Table 2) [124].